SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses
Maaike C Swets, Clark D Russell, Ewen M Harrison, Annemarie B Docherty, Nazir Lone, Michelle Girvan, Hayley E Hardwick, Leonardus G Visser, Peter J M Openshaw, Geert H Groeneveld, Malcolm G Semple, J Kenneth Baillie
Abstract
Measures to reduce transmission of SARS-CoV-2 have also been effective in reducing the transmission of other endemic respiratory viruses.1,2 As many countries decrease the use of such measures,2 we expect that SARS-CoV-2 will circulate with other respiratory viruses, increasing the probability of co-infections.1,3 The clinical outcome of respiratory viral co-infections with SARS-CoV-2 is unknown.
Topics & Concepts
MedicineRespiratory systemCoinfectionTransmission (telecommunications)PandemicVirologyPandemic influenzaRespiratory tract infectionsRespiratory infectionImmunologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirusIntensive care medicineClinical PracticeCoronavirus disease 2019 (COVID-19)Internal medicineInfluenza A virusRespiratory diseaseRespiratory viral infections researchViral Infections and Outbreaks ResearchRespiratory Support and Mechanisms